Tptp

by Genestra Brands · capsule · 60 capsules

  • On the market (NIH)
  • UPC 8 83196 12480 0
  • DSLD label 203053
  • Serving 2 capsules
  • 30 servings

Tptp by Genestra Brands lists one ingredient: 180 mg of bovine (bos taurus) pituitary per serving of 2 capsules. Its current label entered the NIH Dietary Supplement Label Database on May 28, 2019.

What is in Tptp?

Each row as the label prints it, per serving of 2 capsules. The capsule beside an amount places it among every product in the NIH database that lists the same ingredient: the bar is the middle half of their amounts, the line in it the median, the whiskers the 10th and 90th percentiles; the green tick is the FDA Daily Value and the red dashed tick the adult upper limit (IOM).

Tptp: Supplement Facts rows against the market (DSLD label 203053, January 2026 release)
IngredientAmount% DVAmong products listing it
Bovine (Bos taurus) Pituitary180 mgPituitary in TPTP against 82 products180 mg per serving; the middle half of products list 10 mg to 30 mg, the median 17.5 mg.180 mg

Higher than 95% of 82 products listing pituitary (median 17.5 mg). Per day at the most servings: 360 mg.

Source: NIH ODS Dietary Supplement Label Database, label 203053 (entered May 28, 2019), version 9.4.0. See the label on DSLD. Amounts are what the maker printed; DSLD does not test products. Daily Values: the FDA's Daily Value page.

Is that a lot?

The rows in the top or bottom tenth of the products that list the same ingredient, and any above the adult upper limit at the most servings a day the directions give:

  • Its 180 mg of bovine (bos taurus) pituitary (filed by NIH under pituitary) is higher than 95% of the 82 pituitary products that print an amount; 3 list more.

The NIH database records 2 servings a day from the label's directions; its % Daily Values are for adults and children 4 or more years of age. The directions as printed are further down this page.

The Tolerable Upper Intake Level is the most of a nutrient per day, from food, water and supplements together, that is likely to pose no risk for almost all adults (Institute of Medicine, 2011). It does not apply under medical supervision. This page compares labels; it is not medical advice.

Sources: amounts from the DSLD label; Daily Values from 21 CFR 101.9(c)(8)(iv); adult upper limits from the Institute of Medicine's DRI summary tables (2011). How positions are computed.

Which products have the closest formulas?

5 products list the very same ingredients; the nearest amounts come first.

Source: ingredient lists of every product's current label in DSLD (version 9.4.0); similarity weights each shared ingredient by how rare it is.

What does the label say about taking it?

Quoted from the label as DSLD transcribed it: the maker's words, including any claim about what the product does, which the FDA has not evaluated and PlainVitamins does not endorse.

Directions
Recommended dose: Take 2 capsules 2 times daily with meals or as recommended by your health professional.
Warnings
Warning: If you are pregnant, lactating, have high blood pressure or hyperpituitarism, do not use. If you are taking any medication, or have any health condition, consult your health professional before use.
Use only if safety seal is intact.
Keep out of the reach of children.
Storage
Store in a cool, dry place.

Source: label statements in DSLD label 203053.

What else is on the label?

Other ingredients: Cellulose, Vegetarian Capsule, Magnesium Stearate.

How many labels does Tptp have?

2 labels are on file under this name since February 24, 2017: other sizes, label designs and reformulations. The current one leads this page.

  1. Label 203053 (current) Entered May 28, 2019 · on the market · 60 capsules · UPC 8 83196 12480 0
  2. Label 70723 Entered February 24, 2017 · on the market · 60 vegetarian capsules · UPC 883196 12480

Source: DSLD label entry and market events, version 9.4.0 (labels entered through September 25, 2025).

Who makes it?

The label names Seroyal USA (distributor), Pittsburgh, PA. All Genestra Brands products.

Where next?